Healthcare provider profile · identity verified

Richard Kyle Buchman, M.D.

Internal Medicine · INDIANAPOLIS, IN · NPI 1639457807

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	626	223
Amlodipine Besylate	Amlodipine Besylate	521	170
Levothyroxine Sodium	Levothyroxine Sodium	427	146
Lisinopril	Lisinopril	388	120
Metoprolol Succinate	Metoprolol Succinate	328	101
Pantoprazole Sodium	Pantoprazole Sodium	321	92
Metformin Hcl	Metformin Hcl	312	91
Rosuvastatin Calcium	Rosuvastatin Calcium	279	86
Eliquis	Apixaban	220	56
Losartan Potassium	Losartan Potassium	216	83
Furosemide	Furosemide	204	74
Omeprazole	Omeprazole	200	71
Gabapentin	Gabapentin	198	65
Alprazolam	Alprazolam	187	63
Escitalopram Oxalate	Escitalopram Oxalate	187	55
Hydrochlorothiazide	Hydrochlorothiazide	187	71
Simvastatin	Simvastatin	182	56
Potassium Chloride	Potassium Chloride	176	56
Carvedilol	Carvedilol	172	48
Telmisartan	Telmisartan	172	56
Trazodone Hcl	Trazodone Hcl	159	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	154	60
Metformin Hcl Er	Metformin Hcl	136	40
Albuterol Sulfate Hfa	Albuterol Sulfate	128	51
Montelukast Sodium	Montelukast Sodium	123	40
Tamsulosin Hcl	Tamsulosin Hcl	123	47
Pregabalin	Pregabalin	122	36
Ezetimibe	Ezetimibe	120	26
Clopidogrel	Clopidogrel Bisulfate	119	41
Atenolol	Atenolol	118	31
Duloxetine Hcl	Duloxetine Hcl	117	39
Tramadol Hcl	Tramadol Hcl	112	35
Celecoxib	Celecoxib	111	36
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	106	24
Metoprolol Tartrate	Metoprolol Tartrate	105	41
Lorazepam	Lorazepam	104	31
Allopurinol	Allopurinol	103	40
Sertraline Hcl	Sertraline Hcl	98	29
Glipizide Er	Glipizide	93	27
Jardiance	Empagliflozin	93	25
Farxiga	Dapagliflozin Propanediol	91	23
Fluticasone Propionate	Fluticasone Propionate	91	31
Ozempic	Semaglutide	85	22
Hydralazine Hcl	Hydralazine Hcl	81	20
Meloxicam	Meloxicam	81	33
Spironolactone	Spironolactone	78	21
Famotidine	Famotidine	77	25
Citalopram Hbr	Citalopram Hydrobromide	72	23
Prednisone	Prednisone	70	43
Mirtazapine	Mirtazapine	69	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	18
Synthroid	Levothyroxine Sodium	66	18
Glipizide	Glipizide	65	18
Pravastatin Sodium	Pravastatin Sodium	63	24
Venlafaxine Hcl Er	Venlafaxine Hcl	63	16
Aripiprazole	Aripiprazole	61	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	61	15
Januvia	Sitagliptin Phosphate	60	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	22
Irbesartan	Irbesartan	51	14
Warfarin Sodium	Warfarin Sodium	50	15
Zolpidem Tartrate	Zolpidem Tartrate	50	18
Buspirone Hcl	Buspirone Hcl	49	17
Dicyclomine Hcl	Dicyclomine Hcl	46	13
Bupropion Xl	Bupropion Hcl	44	18
Ventolin Hfa	Albuterol Sulfate	43	11
Xarelto	Rivaroxaban	43	suppressed
Finasteride	Finasteride	41	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	13
Ondansetron Odt	Ondansetron	39	20
Donepezil Hcl	Donepezil Hcl	38	suppressed
Nebivolol Hcl	Nebivolol Hcl	36	13
Torsemide	Torsemide	36	13
Diazepam	Diazepam	35	11
Gemtesa	Vibegron	35	suppressed
Chlorthalidone	Chlorthalidone	34	13
Oxycodone Hcl	Oxycodone Hcl	34	12
Nifedipine Er	Nifedipine	33	12
Valsartan	Valsartan	33	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	20
Propranolol Hcl	Propranolol Hcl	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Lovastatin	Lovastatin	29	13
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	11
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Doxycycline Hyclate	Doxycycline Hyclate	27	18
Glimepiride	Glimepiride	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	11
Temazepam	Temazepam	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Azelastine Hcl	Azelastine Hcl	25	15
Memantine Hcl	Memantine Hcl	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Belsomra	Suvorexant	24	11
Clonidine	Clonidine	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Ramipril	Ramipril	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	11
Sucralfate	Sucralfate	24	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Topiramate	Topiramate	23	suppressed
Cephalexin	Cephalexin	22	17
Trulicity	Dulaglutide	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Vraylar	Cariprazine Hcl	20	suppressed
Armour Thyroid	Thyroid,pork	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Estradiol	Estradiol	18	suppressed
Linzess	Linaclotide	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	11
Rexulti	Brexpiprazole	18	suppressed
Baclofen	Baclofen	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Colestipol Hcl	Colestipol Hcl	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Indapamide	Indapamide	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Nystatin	Nystatin	13	12
Vascepa	Icosapent Ethyl	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Letrozole	Letrozole	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error